Skip Navigation

MediXall Group, Inc. Announces Expansion into Laboratory Testing with Appointment of Industry Leader, John J. Howard

Fort Lauderdale, Florida, Sept. 10, 2018 (NewMediaWire) -- MediXall Group Inc., (OTCQB: MDXL), creator of, a new generation healthcare marketplace platform designed to address the growing need of self-pay and high deductible consumers for greater transparency and price competition in their healthcare costs, is pleased to announce today the Company’s expansion into the clinical laboratory testing arena with the appointment of John J. Howard as Senior Vice President of Laboratory Services. Mr. Howard is an industry leader in the clinical laboratory testing space with over 29 years of experience in Laboratory medicine. As head of the MediXall Laboratory Division and Operations, Mr. Howard will guide the Company to provide clinical laboratory testing for its new laboratory platform, with availability before the end of the 4th quarter of 2018. 

To streamline the clinical laboratory test ordering process for physicians, Mr. Howard is negotiating with two major laboratory testing companies that will allow the Company to develop custom health screening lab tests panels and profiles, which are groups of tests that are routinely ordered to determine a person's general health status, as well as pricing for the platform. The Laboratory Testing Panels include, but not limited to male and female specific panels, organ-specific panels and cancer marker panels.  Moreover, will offer toxicology panels for urine drug testing and confirmations and different hormone panels as well. With the addition of clinical laboratory testing services, will offer physicians a robust test menu of proprietary cost-effective lab tests panels and profiles, as well as individual tests that they can order for their patients.

By launching clinical laboratory testing services and the associated Referral/ordering program, the platform will provide a seamless ordering experience for physicians to search, compare, and order pre-curated panels or design custom lab test orders for their patients. Through this innovative toolkit, healthcare providers can decrease patients’ out-of-pocket expenses, streamline lab testing ordering process, and improve the patient-physician relationship by facilitating a transparent conversation about cost and value.

“We are very excited to have John Howard join our team as we seek to broaden's scope with an expansion into clinical laboratory testing,” said Michael Swartz, President of MediXall. “Mr. Howard is widely respected in the clinical laboratory testing space and understands the power we have to reimagine the way that testing is ordered and delivered. His insight and direction will be invaluable as we address our customers’ needs by introducing increased services, expand into additional markets, and form new partnerships.”

John J. Howard is well prepared to lead MediXall’s Laboratory Division and Operations. Mr. Howard holds a Masters in Hospital Administration from Pace University in New York, and got his earliest experience working as a Medical Technologist in clinical laboratories. He is licensed in Chemistry, Hematology, Serology, Immunohematology, Microbiology, Parasitology, Mycology, and Molecular Pathology. He later founded and built a large Clinical Laboratory, over 175 full-time employees, with US and International clientele. He has also owned and operated Diagnostic Centers, Consulting Companies, and most recently, invented and founded PocketMD, LLC. PocketMD provides all your medical records on credit-card-size cd that you carry in your wallet or purse. 

“I will bring all of the industry and operational wisdom and knowledge gained from nearly three decades’ experience owning and operating my own clinical laboratory to guide and grow the clinical laboratory testing for MediXall,” said John Howard. “MediXall’s Laboratory Division will be able to provide exceptional quality testing products and superlative service at the lowest price point.”

About is a new generation healthcare marketplace platform designed to address the growing need of self-pay and high deductible consumers for greater transparency and price competition in their healthcare costs. With MediXall, consumers now have the option to search for doctors or dentists and book appointments based on cost, distance, ratings, and availability at the click of a button.  By delivering a solution that better connects consumers with high-quality healthcare providers and wellness services, enables healthcare providers to engage consumers with a level of price transparency and digital convenience that they have come to expect in every other aspect of their lives. In this era of rapidly increasing deductibles and healthcare costs, the cloud-based platform is designed to be transformational and disruptive to traditional methods of medical care and provisioning of medical services to the consumer. For more information, please visit or call (954) 440-4678.

About MediXall Group, Inc.

MediXall Group is a technology and innovation-driven organization purposefully designed and structured to bring effective change to the U.S. healthcare industry that is actively trading on the OTCQB under the symbol “MDXL.” The Company believes its revolutionary approach will help drive much-needed change that it envisions is needed in the current healthcare system. The mission of the MediXall Group is to revolutionize the medical industry by improving communication; providing better technology and support services; and enabling more efficient, cost-effective healthcare for the consumer. By approaching the healthcare ecosystem as a whole, MediXall creates, invests and incubates companies that embody its mission statement.

Safe Harbor Statement

This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. These forward-looking statements are based on current plans and expectations of management and are subject to a number of uncertainties and risks that could significantly affect the Company’s current plans and expectations, as well as future results of operations and financial condition. Specifically, the Company’s ability to raise additional capital, execute its business plan and strategy, sustain or increase gross margins, achieve profitability and build shareholder value are forward-looking statements. A more extensive listing of risks and factors that may affect the Company’s business prospects and cause actual results to differ materially from those described in the forward-looking statements can be found in the reports and other documents filed by the Company with the Securities and Exchange Commission. The Company undertakes no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise.

Media Contact Information:

Kip Hunter Marketing - 954-765-1329

Nicole Lewis